543 related articles for article (PubMed ID: 24798211)
1. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.
Piechota-Polanczyk A; Fichna J
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):605-20. PubMed ID: 24798211
[TBL] [Abstract][Full Text] [Related]
2. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.
Balmus IM; Ciobica A; Trifan A; Stanciu C
Saudi J Gastroenterol; 2016; 22(1):3-17. PubMed ID: 26831601
[TBL] [Abstract][Full Text] [Related]
3. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.
Tian T; Wang Z; Zhang J
Oxid Med Cell Longev; 2017; 2017():4535194. PubMed ID: 28744337
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?
Rezaie A; Parker RD; Abdollahi M
Dig Dis Sci; 2007 Sep; 52(9):2015-21. PubMed ID: 17404859
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.
Sahoo DK; Heilmann RM; Paital B; Patel A; Yadav VK; Wong D; Jergens AE
Front Endocrinol (Lausanne); 2023; 14():1217165. PubMed ID: 37701897
[TBL] [Abstract][Full Text] [Related]
6. Implications of Antioxidant Systems in Inflammatory Bowel Disease.
Guan G; Lan S
Biomed Res Int; 2018; 2018():1290179. PubMed ID: 29854724
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.
Pereira C; Grácio D; Teixeira JP; Magro F
Inflamm Bowel Dis; 2015 Oct; 21(10):2403-17. PubMed ID: 26193347
[TBL] [Abstract][Full Text] [Related]
8. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease.
Bourgonje AR; Feelisch M; Faber KN; Pasch A; Dijkstra G; van Goor H
Trends Mol Med; 2020 Nov; 26(11):1034-1046. PubMed ID: 32620502
[TBL] [Abstract][Full Text] [Related]
11. The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.
Szandruk M; Merwid-Ląd A; Szeląg A
Inflammopharmacology; 2018 Apr; 26(2):571-581. PubMed ID: 28337639
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.
Perera AP; Kunde D; Eri R
Curr Pharm Des; 2017; 23(16):2321-2327. PubMed ID: 28155620
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.
Bragg MA; Breaux WA; M'Koma AE
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37476546
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients.
Bouzid D; Gargouri B; Mansour RB; Amouri A; Tahri N; Lassoued S; Masmoudi H
Saudi J Gastroenterol; 2013; 19(3):131-5. PubMed ID: 23680711
[TBL] [Abstract][Full Text] [Related]
15. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease.
Sreedhar R; Arumugam S; Thandavarayan RA; Karuppagounder V; Watanabe K
Drug Discov Today; 2016 May; 21(5):843-9. PubMed ID: 26995272
[TBL] [Abstract][Full Text] [Related]
16. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD.
Dudzińska E; Gryzinska M; Ognik K; Gil-Kulik P; Kocki J
Oxid Med Cell Longev; 2018; 2018():7918261. PubMed ID: 30057685
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
[TBL] [Abstract][Full Text] [Related]
19. Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-κB pathways.
Chen YE; Xu SJ; Lu YY; Chen SX; Du XH; Hou SZ; Huang HY; Liang J
Chem Biol Interact; 2021 Aug; 344():109512. PubMed ID: 33974900
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity.
Linares V; Alonso V; Domingo JL
Expert Opin Drug Saf; 2011 Mar; 10(2):253-63. PubMed ID: 21219240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
